Drug delivery systems for enhanced tumour treatment by eliminating intra-tumoral bacteria.

Autor: Liu, Ziyi, Ma, Yige, Ye, Jinxin, Li, Guofeng, Kang, Xiaoxu, Xie, Wensheng, Wang, Xing
Zdroj: Journal of Materials Chemistry B; 2/7/2024, Vol. 12 Issue 5, p1194-1207, 14p
Abstrakt: Cancer remains one of the serious threats to human health. The relationship between bacteria and various tumours has been widely reported in recent years, and studies on intra-tumoral bacteria have become important as intra-tumoral bacteria directly affect the tumorigenesis, progression, immunity and metastatic processes. Therefore, eliminating these commensal intra-tumoral bacteria while treating tumour is expected to be a potential strategy to further enhance the clinical outcome of tumour therapy. Drug delivery systems (DDSs) are widely used to deliver antibiotics and chemotherapeutic drugs for antibacterial and anticancer applications, respectively. Thus, this review firstly provides a comprehensive summary of the association between intra-tumoral bacteria and a host of tumours, followed by a description of advanced DDSs for improving the therapeutic efficacy of cancer treatment through the elimination of intra-tumoral bacteria. It is hoped that this review will provide guidelines for the therapeutic and "synergistic antimicrobial and antitumour" drug delivery strategy. [ABSTRACT FROM AUTHOR]
Databáze: Complementary Index